BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27618820)

  • 1. Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea.
    Carter GC; Kaltenboeck A; Ivanova J; Liepa AM; San Roman A; Koh M; Rajan N; Cheng R; Birnbaum HG; Kim JS; Bang YJ
    Cancer Res Treat; 2017 Jul; 49(3):578-587. PubMed ID: 27618820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns in patients with advanced gastric cancer in Taiwan.
    Cuyun Carter G; Kaltenboeck A; Ivanova J; Liepa AM; San Roman A; Koh M; Rajan N; Cheng R; Birnbaum H; Chen JS
    Asia Pac J Clin Oncol; 2017 Jun; 13(3):185-194. PubMed ID: 27108762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Patterns Among Patients with Metastatic and/or Unresectable Gastric Cancer in Brazil.
    de Alencar Camara Vieira FM; de Souza Victorino APO; de Iracema Gomes Cubero D; Beato CAM; Minowa E; Julian GS; Novick D
    J Gastrointest Cancer; 2019 Dec; 50(4):780-793. PubMed ID: 30078125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.
    Brown J; Liepa AM; Bapat B; Madhwani S; Lorenzen S; García-Foncillas J; Candrilli SD; Kaye JA
    Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13213. PubMed ID: 31883156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study.
    Choi IS; Kim JH; Lee JH; Suh KJ; Lee JY; Kim JW; Kim SH; Kim JW; Lee JO; Kim YJ; Bang SM; Lee JS; Lee KW
    PLoS One; 2018; 13(10):e0205853. PubMed ID: 30346970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia.
    Novick D; Leonardi F; Lee Kay Pen D; Montoya-Restrepo ME; Avendaño C; Siddi S; Moneta MV; Haro JM; Velasquez JC
    J Med Econ; 2019 Sep; 22(9):891-900. PubMed ID: 31066594
    [No Abstract]   [Full Text] [Related]  

  • 7. Population-based outcomes research on treatment patterns and impact of chemotherapy in older patients with metastatic gastric cancer.
    Lee KW; Lee JH; Kim JW; Kim JW; Ahn S; Kim JH
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):687-97. PubMed ID: 26567125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
    Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
    Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study.
    Tjulandin SA; Tryakin AA; Besova NS; Sholokhova E; Ivanova JI; Cheng WY; Schmerold LM; Thompson-Leduc P; Novick D
    J Drug Assess; 2019; 8(1):150-158. PubMed ID: 31656688
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrospective analysis of patients with locally advanced or metastatic gastric cancer in Argentina.
    Novick D; Mendez G; Carballido M; Rizzo M; O'Connor JM; Castillo J; Lee Kay Pen D; Siddi S; Rodante D; Moneta MV; Haro JM
    Medwave; 2019 Sep; 19(8):e7692. PubMed ID: 31596840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.
    Kang JH; Lee SI; Lim DH; Park KW; Oh SY; Kwon HC; Hwang IG; Lee SC; Nam E; Shin DB; Lee J; Park JO; Park YS; Lim HY; Kang WK; Park SH
    J Clin Oncol; 2012 May; 30(13):1513-8. PubMed ID: 22412140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
    Seo S; Park SJ; Ryu MH; Park SR; Ryoo BY; Park YS; Na YS; Lee CW; Lee JK; Kang YK
    Oncotarget; 2017 May; 8(20):33844-33854. PubMed ID: 27802183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen.
    Kim SH; Lee GW; Go SI; Cho SH; Kim HJ; Kim HG; Kang JH
    Am J Clin Oncol; 2010 Dec; 33(6):572-6. PubMed ID: 20042971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany.
    Luna J; Picker N; Wilke T; Lutz M; Hess J; Mörtl B; Xiong Y; Götze TO
    BMC Cancer; 2024 Apr; 24(1):462. PubMed ID: 38614966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer.
    McLean J; Rho YS; Kuruba G; Mamo A; Gilabert M; Kavan T; Panasci L; Melnychuk D; Batist G; Kavan P
    Clin Colorectal Cancer; 2016 Jun; 15(2):135-40. PubMed ID: 26553578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
    Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
    BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy.
    Goto A; Sukawa Y; Igarashi H; Onodera K; Aoki Y; Suzuki K; Yonezawa K; Yawata A; Kobayashi T; Kaneto H; Shimizu H; Wakasugi H; Matsunaga Y; Itoh M; Okuda H; Arimura Y; Shinomura Y
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1461-6. PubMed ID: 21945893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world treatment patterns and outcomes of patients with stage IV squamous cell carcinoma of the head and neck.
    Byrne K; Zanotti G; Hallworth P; Roughley A; Martini JF; Uehara R; Iyer S
    Future Oncol; 2019 Feb; 15(6):611-623. PubMed ID: 30426780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy.
    Cowey CL; Robert NJ; Espirito JL; Davies K; Frytak J; Lowy I; Fury MG
    Cancer Med; 2020 Oct; 9(20):7381-7387. PubMed ID: 32578965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
    Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
    Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.